tradingkey.logo
tradingkey.logo
Search

Tenax Therapeutics Inc

TENX
Add to Watchlist
14.520USD
+0.820+5.99%
Close 07-31 16:00ETQuotes delayed by 15 min
463.91MMarket Cap
LossP/E TTM

TENX Income Statement

You can find the annual or quarterly income statement of Tenax Therapeutics Inc here for insights into the performance and operational efficiency of Tenax Therapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
--0.00
----
--49.29K
-100.00%0.00
-100.00%0.00
-100.00%0.00
1372.45%42.27K
-88.73%59.06K
1587.15%193.31K
612.35%63.78K
-38.56%2.87K
1811.38%524.01K
-80.74%11.46K
--8.95K
--4.67K
--27.41K
--59.48K
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
--0.00
----
--49.29K
-100.00%0.00
-100.00%0.00
-100.00%0.00
1372.45%42.27K
-88.73%59.06K
1587.15%193.31K
612.35%63.78K
-38.56%2.87K
1811.38%524.01K
-80.74%11.46K
--8.95K
--4.67K
--27.41K
--59.48K
Cost of revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-73.27%410.00
-63.27%3.35K
365.40%27.51K
629.53%26.53K
-38.93%1.53K
-13.01%9.13K
-82.92%5.91K
--3.64K
--2.51K
--10.50K
--34.60K
Operating expenses
59.29%18.78M
46.17%16.57M
125.49%16.45M
263.85%16.81M
221.13%11.79M
190.10%11.34M
118.35%7.29M
118.14%4.62M
197.05%3.67M
153.88%3.91M
30.78%3.34M
-27.42%2.12M
-56.81%1.24M
-43.37%1.54M
-20.46%2.55M
-23.27%2.92M
45.68%2.86M
-88.55%2.72M
13.36%3.21M
70.88%3.80M
-8.37%1.96M
791.01%23.75M
0.71%2.83M
-1.56%2.23M
17.83%2.14M
60.40%2.67M
26.32%2.81M
45.44%2.26M
-3.66%1.82M
35.87%1.66M
61.13%2.23M
18.60%1.55M
-37.34%1.89M
-65.04%1.22M
-69.34%1.38M
-70.88%1.31M
-35.47%3.01M
-38.67%3.50M
8.98%4.51M
43.57%4.50M
12.74%4.67M
136.11%5.71M
--4.14M
26.72%3.13M
90.64%4.14M
35.53%2.42M
55.44%2.47M
109.67%2.17M
8.75%1.78M
-30.80%1.28M
-15.28%1.59M
-50.21%1.04M
-34.09%1.64M
--1.84M
--1.88M
--2.08M
--2.49M
R&D expenses
109.93%12.85M
103.04%11.54M
455.33%25.51M
231.87%10.33M
162.97%6.12M
112.40%5.68M
170.32%4.59M
191.98%3.11M
1076.15%2.33M
906.89%2.68M
49.74%1.70M
-30.80%1.07M
-87.02%197.90K
-77.44%265.74K
23.95%1.13M
32.51%1.54M
119.91%1.52M
-94.74%1.18M
2.77%915.60K
10.45%1.16M
-45.62%693.22K
1566.72%22.38M
-37.35%890.96K
14.77%1.05M
96.35%1.27M
178.09%1.34M
180.54%1.42M
152.87%916.98K
108.66%649.25K
724.00%482.77K
49750.83%506.94K
42.78%362.63K
-74.56%311.15K
-97.14%58.59K
-100.04%-1.02K
-92.15%253.97K
-64.36%1.22M
-47.98%2.05M
33.02%2.53M
165.34%3.23M
34.66%3.43M
311.69%3.94M
--1.90M
79.96%1.22M
244.82%2.55M
25.54%957.92K
88.43%677.41K
24.50%739.01K
19.74%763.06K
15.63%835.02K
-40.08%359.51K
21.49%593.59K
-2.25%637.27K
--722.16K
--599.93K
--488.58K
--651.96K
Depreciation, depletion, and amortization
----
----
--0.00
--0.00
--0.00
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
249.89%4.71K
-17.36%1.00K
-19.03%1.00K
-36.07%895.00
20.52%1.34K
19.68%1.21K
23.50%1.24K
23.35%1.40K
13.99%1.12K
6.65%1.01K
-3.57%1.00K
1.98%1.14K
-25.66%979.00
-27.58%948.00
-20.23%1.04K
-0.09%1.11K
-8.67%1.32K
-38.60%1.31K
-56.67%1.30K
-62.87%1.11K
-52.28%1.44K
-32.17%2.13K
-28.01%3.00K
-25.60%3.00K
-31.64%3.02K
-37.14%3.14K
-17.86%4.17K
-19.36%4.03K
-91.82%4.42K
-90.74%5.00K
-90.76%5.07K
-90.99%5.00K
--54.07K
-3.06%54.00K
2.92%54.89K
4.22%55.49K
7.61%55.70K
4.28%53.34K
29.84%53.24K
31.65%53.38K
9.50%51.76K
-10.26%51.15K
-66.02%41.00K
--40.54K
--47.27K
--57.00K
--120.68K
Other operating expenses
----
----
---14.97M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-60.05%-144.32K
-51.30%-221.05K
----
---266.55K
---90.17K
---146.10K
---78.24K
--0.00
Operating profit
-59.29%-18.78M
-46.17%-16.57M
-125.49%-16.45M
-263.85%-16.81M
-221.13%-11.79M
-190.10%-11.34M
-118.35%-7.29M
-118.14%-4.62M
-197.05%-3.67M
-153.88%-3.91M
-30.78%-3.34M
27.42%-2.12M
56.81%-1.24M
43.37%-1.54M
20.46%-2.55M
23.27%-2.92M
-45.68%-2.86M
88.55%-2.72M
-13.36%-3.21M
-70.88%-3.80M
8.37%-1.96M
-791.01%-23.75M
-0.71%-2.83M
1.56%-2.23M
-17.83%-2.14M
-60.40%-2.67M
-26.32%-2.81M
-45.44%-2.26M
3.66%-1.82M
-35.87%-1.66M
-61.13%-2.23M
-18.60%-1.55M
37.34%-1.89M
65.04%-1.22M
69.34%-1.38M
70.88%-1.31M
35.47%-3.01M
38.67%-3.50M
-10.30%-4.51M
-43.57%-4.50M
-12.74%-4.67M
-136.11%-5.71M
---4.09M
-28.92%-3.13M
-95.96%-4.14M
-52.01%-2.42M
-53.06%-2.43M
-312.50%-2.11M
2.36%-1.59M
33.94%-1.21M
15.22%-1.59M
75.05%-512.54K
32.95%-1.63M
---1.83M
---1.87M
---2.05M
---2.43M
Net non-operating interest income (expenses)
Non-operating interest income
2.83%981.00K
-7.42%861.00K
-10.65%918.00K
53.00%1.02M
809.58%954.00K
--930.00K
--1.03M
340.97%664.72K
-25.01%104.88K
----
----
--150.74K
--139.86K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
----
--0.00
----
-100.00%0.00
-100.00%0.00
----
18.27%6.31K
0.69%9.19K
8.34%7.96K
--369.03K
1334.68%5.34K
514.96%9.13K
184.11%7.35K
--0.00
--372.00
341.67%1.48K
322.02%2.59K
-100.00%0.00
-100.00%0.00
-17.24%336.00
--613.00
--611.00
--610.00
--406.00
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--1.79K
-98.62%968.00
-100.00%59.00
-92.95%46.26K
-91.49%69.97K
63.32%1.42M
-65.95%655.80K
-18.26%623.25K
-84.62%821.78K
-0.49%867.52K
341.93%1.93M
--762.50K
--5.34M
--871.77K
--435.80K
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
----
----
-3114.44%-33.27M
--0.00
--0.00
----
---1.03M
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
-149.18%-27.28K
96.54%-2.94K
---170.30K
---47.48K
--55.47K
---85.00K
--0.00
--0.00
Other non-operating income (expenses)
100.00%0.00
---4.00K
-2701.16%-9.00K
---15.00K
-1476.15%-9.00K
----
-99.93%346.00
--0.00
171.79%654.00
-16.14%117.45K
8218.20%484.37K
-100.00%0.00
-138.68%-911.00
45279.03%140.06K
101.15%5.82K
-63.67%1.32K
-99.05%2.35K
-114.52%-310.00
-12416.59%-508.43K
-31.26%3.64K
11895.34%247.82K
-80.31%2.13K
-81.01%4.13K
-85.57%5.30K
-103.61%-2.10K
-75.55%10.84K
632.19%21.74K
56.88%36.71K
172.73%58.12K
47.34%44.33K
-110.61%-4.08K
-69.30%23.40K
-24.43%21.31K
-86.53%30.09K
-76.55%38.49K
-66.41%76.23K
-6.09%28.20K
-35.02%223.30K
19.62%164.13K
-15.11%226.91K
-65.99%30.03K
18.01%343.67K
--137.21K
131.46%267.29K
24157.49%88.29K
206439.72%291.22K
-263120.43%-849.56K
94.69%-367.00
-99.05%141.00
104.75%3.47K
-84.98%323.00
-75.99%-6.91K
372.46%14.80K
---72.95K
--2.15K
---3.93K
---5.43K
Income before tax
----
-51.00%-15.72M
-147.96%-15.54M
-299.04%-15.80M
-203.36%-10.85M
-173.98%-10.41M
-94.29%-6.27M
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.80M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
31.49%-2.55M
23.22%-2.92M
-66.63%-2.86M
88.54%-2.72M
-31.47%-3.72M
-71.08%-3.80M
20.01%-1.72M
-794.59%-23.75M
-1.36%-2.83M
0.15%-2.22M
-21.86%-2.15M
-64.13%-2.65M
-25.12%-2.79M
-45.26%-2.22M
5.68%-1.76M
-35.58%-1.62M
-66.05%-2.23M
-24.03%-1.53M
37.46%-1.87M
63.58%-1.19M
96.43%-1.34M
71.12%-1.23M
35.66%-2.99M
38.91%-3.28M
-654.14%-37.61M
-48.99%-4.27M
-14.46%-4.64M
-146.92%-5.36M
---4.99M
14.40%-2.87M
-14.82%-4.05M
3.29%-2.17M
-38.87%-3.35M
-126.77%-3.53M
37.40%-2.25M
28.90%-1.86M
66.94%-2.41M
46.85%-1.56M
-25.00%-3.59M
---2.61M
---7.30M
---2.93M
---2.87M
Income tax
----
----
--0.00
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
----
----
---7.96M
----
--0.00
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
----
-51.00%-15.72M
-147.96%-15.54M
-299.04%-15.80M
-203.36%-10.85M
-173.98%-10.41M
-94.29%-6.27M
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.80M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
31.49%-2.55M
23.22%-2.92M
-66.63%-2.86M
88.54%-2.72M
-31.47%-3.72M
-71.08%-3.80M
20.01%-1.72M
-794.59%-23.75M
-1.36%-2.83M
0.15%-2.22M
-21.86%-2.15M
-64.13%-2.65M
-25.12%-2.79M
-45.26%-2.22M
5.68%-1.76M
-35.58%-1.62M
-66.05%-2.23M
-24.03%-1.53M
37.46%-1.87M
63.58%-1.19M
95.47%-1.34M
71.12%-1.23M
35.66%-2.99M
38.91%-3.28M
-494.48%-29.65M
-48.99%-4.27M
-14.46%-4.64M
-146.92%-5.36M
---4.99M
14.40%-2.87M
-14.82%-4.05M
3.29%-2.17M
-38.87%-3.35M
-126.77%-3.53M
37.40%-2.25M
28.90%-1.86M
66.94%-2.41M
46.85%-1.56M
-25.00%-3.59M
---2.61M
---7.30M
---2.93M
---2.87M
Net income from continuous operations
-64.13%-17.80M
-51.00%-15.72M
-147.96%-15.54M
-299.04%-15.80M
-203.36%-10.85M
-173.98%-10.41M
-94.29%-6.27M
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.80M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
31.49%-2.55M
23.22%-2.92M
-66.63%-2.86M
88.54%-2.72M
-31.47%-3.72M
-71.08%-3.80M
20.01%-1.72M
-794.59%-23.75M
-1.36%-2.83M
0.15%-2.22M
-21.86%-2.15M
-64.13%-2.65M
-25.12%-2.79M
-45.26%-2.22M
5.68%-1.76M
-35.58%-1.62M
-66.05%-2.23M
-24.03%-1.53M
37.46%-1.87M
63.58%-1.19M
95.47%-1.34M
71.12%-1.23M
35.66%-2.99M
38.91%-3.28M
-494.48%-29.65M
-48.99%-4.27M
-14.46%-4.64M
-146.92%-5.36M
---4.99M
14.40%-2.87M
-14.82%-4.05M
3.29%-2.17M
-38.87%-3.35M
-126.77%-3.53M
37.40%-2.25M
28.90%-1.86M
66.94%-2.41M
46.85%-1.56M
-25.00%-3.59M
---2.61M
---7.30M
---2.93M
---2.87M
Non-recurring net income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-64.13%-17.80M
-51.00%-15.72M
-147.96%-15.54M
-299.04%-15.80M
-203.36%-10.85M
-173.98%-10.41M
-94.29%-6.27M
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.80M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
31.49%-2.55M
23.22%-2.92M
-66.63%-2.86M
88.54%-2.72M
-31.47%-3.72M
-71.08%-3.80M
20.01%-1.72M
-794.59%-23.75M
-1.36%-2.83M
0.15%-2.22M
-21.86%-2.15M
-64.13%-2.65M
70.80%-2.79M
-45.26%-2.22M
5.68%-1.76M
-35.58%-1.62M
-611.59%-9.56M
-24.03%-1.53M
37.46%-1.87M
63.58%-1.19M
95.47%-1.34M
71.12%-1.23M
35.66%-2.99M
38.91%-3.28M
-494.48%-29.65M
-48.99%-4.27M
-14.46%-4.64M
-146.92%-5.36M
---4.99M
35.50%-2.87M
33.34%-4.05M
49.97%-2.17M
-84.29%-4.45M
-290.64%-6.08M
-21.00%-4.34M
-7.75%-2.82M
66.94%-2.41M
46.85%-1.56M
-25.00%-3.59M
---2.61M
---7.30M
---2.93M
---2.87M
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
----
--7.33M
----
----
----
----
----
----
----
--0.00
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--1.10M
--2.55M
--2.09M
--958.07K
----
----
----
----
----
----
----
Net income attributable to common shareholders
-64.13%-17.80M
-51.00%-15.72M
-147.96%-15.54M
-299.04%-15.80M
-203.36%-10.85M
-173.98%-10.41M
-94.29%-6.27M
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.80M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
31.49%-2.55M
23.22%-2.92M
-66.63%-2.86M
88.54%-2.72M
-31.47%-3.72M
-71.08%-3.80M
20.01%-1.72M
-794.59%-23.75M
-1.36%-2.83M
0.15%-2.22M
-21.86%-2.15M
-64.13%-2.65M
70.80%-2.79M
-45.26%-2.22M
5.68%-1.76M
-35.58%-1.62M
-611.59%-9.56M
-24.03%-1.53M
37.46%-1.87M
63.58%-1.19M
95.47%-1.34M
71.12%-1.23M
35.66%-2.99M
38.91%-3.28M
-494.48%-29.65M
-48.99%-4.27M
-14.46%-4.64M
-146.92%-5.36M
---4.99M
35.50%-2.87M
33.34%-4.05M
49.97%-2.17M
-84.29%-4.45M
-290.64%-6.08M
-21.00%-4.34M
-7.75%-2.82M
66.94%-2.41M
46.85%-1.56M
-25.00%-3.59M
---2.61M
---7.30M
---2.93M
---2.87M
Basic earnings per share
-27.68%-0.35
-22.15%-0.35
-119.52%-0.38
-112.48%-0.40
84.99%-0.27
90.87%-0.28
98.40%-0.17
97.17%-0.19
54.37%-1.83
74.25%-3.12
89.16%-10.79
96.27%-6.61
97.80%-4.00
93.00%-12.10
57.74%-99.59
26.51%-177.23
-13.82%-181.60
93.40%-172.75
95.35%-235.66
15.64%-241.17
56.61%-159.55
-329.84%-2.62K
-666.27%-5.07K
45.84%-285.87
16.69%-367.74
-15.01%-609.01
91.69%-661.94
68.49%-527.79
78.53%-441.39
60.53%-529.54
-423.26%-7.97K
-19.76%-1.68K
39.26%-2.06K
63.99%-1.34K
95.49%-1.52K
71.24%-1.40K
35.92%-3.38K
38.95%-3.73K
-494.45%-33.74K
-48.99%-4.86K
-14.40%-5.28K
-142.89%-6.10K
---5.68K
76.46%-3.26K
88.28%-4.62K
96.20%-2.51K
70.20%-13.87K
-26.75%-39.39K
13.14%-66.04K
14.72%-49.28K
72.54%-46.55K
60.55%-31.07K
3.12%-76.04K
---57.79K
---169.50K
---78.77K
---78.49K
Diluted earnings per share
-27.68%-0.35
-22.15%-0.35
-119.52%-0.38
-112.48%-0.40
84.99%-0.27
90.87%-0.28
98.40%-0.17
97.17%-0.19
54.37%-1.83
74.25%-3.12
89.16%-10.79
96.27%-6.61
97.80%-4.00
93.00%-12.10
57.74%-99.59
26.51%-177.23
-13.82%-181.60
93.40%-172.75
95.35%-235.66
15.64%-241.17
56.61%-159.55
-329.84%-2.62K
-666.27%-5.07K
45.84%-285.87
16.69%-367.74
-15.01%-609.01
91.69%-661.94
68.49%-527.79
78.53%-441.39
60.53%-529.54
-423.26%-7.97K
-19.76%-1.68K
39.26%-2.06K
63.99%-1.34K
95.49%-1.52K
71.24%-1.40K
35.92%-3.38K
38.95%-3.73K
-494.45%-33.74K
-48.99%-4.86K
-14.40%-5.28K
-142.89%-6.10K
---5.68K
76.46%-3.26K
88.28%-4.62K
96.20%-2.51K
70.20%-13.87K
-26.75%-39.39K
13.14%-66.04K
14.72%-49.28K
72.54%-46.55K
60.55%-31.07K
3.12%-76.04K
---57.79K
---169.50K
---78.77K
---78.49K
Dividend per share
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Tenax Therapeutics Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing TENX stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Tenax Therapeutics Inc's net income for the year?

Tenax Therapeutics Inc posted -52.60M in net income for fiscal year 2025.

How much net income did Tenax Therapeutics Inc post in the last quarter?

Tenax Therapeutics Inc reported -17.80M in net income for the latest quarter。

What was Tenax Therapeutics Inc's annual operating profit?

Tenax Therapeutics Inc's operating income was -56.38M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.